ReviewCurrent opinion in hematology2009
Core binding factor acute myeloid leukemia (CBF-AML): is high-dose Ara-C (HDAC) consolidation as effective as you think?
Hervé Dombret et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papertrialcites it